Flora E. Van Leeuwen

Flora E. Van Leeuwen's AcademicInfluence.com Rankings

Medical

#3283

Historical Rank

Epidemiology

#564

Historical Rank

medical Degrees

Download Badge

Medical

Flora E. Van Leeuwen's Degrees

PhD Epidemiology University of Amsterdam
Masters Biomedical Sciences University of Amsterdam

Why Is Flora E. Van Leeuwen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Flora E. Van Leeuwen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers (2017) (1644)
Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies (2010) (1025)
Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. (2007) (768)
Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. (2007) (765)
Long-term cause-specific mortality of patients treated for Hodgkin's disease. (2003) (678)
Late cardiotoxicity after treatment for Hodgkin lymphoma. (2007) (669)
Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. (2003) (633)
Health Council of the Netherlands: No need to change from SAR to time-temperature relation in electromagnetic fields exposure limits (2011) (563)
Physical Activity and Breast Cancer: A Systematic Review (2007) (540)
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. (2011) (536)
Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. (2002) (531)
Risk of second malignant neoplasms among long-term survivors of testicular cancer. (1997) (473)
Leukemia following Hodgkin's disease. (1990) (456)
Second cancer risk following Hodgkin's disease: a 20-year follow-up study. (1994) (455)
Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. (2002) (441)
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma. (2015) (427)
Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. (2000) (419)
Cancer risks in BRCA2 families: estimates for sites other than breast and ovary (2005) (410)
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk (2013) (405)
Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. (2007) (405)
Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. (2005) (399)
Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. (2003) (395)
Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk. (2015) (360)
Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. (1995) (358)
Cardiometabolic differences in children born after in vitro fertilization: follow-up study. (2008) (355)
Anaplastic large-cell lymphoma in women with breast implants. (2008) (352)
Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. (2002) (334)
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. (2000) (333)
Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer. (2005) (319)
Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma. (2016) (291)
Effects of subfertility cause, smoking and body weight on the success rate of IVF. (2005) (281)
High risk of symptomatic cardiac events in childhood cancer survivors. (2012) (268)
Testicular cancer survivorship: research strategies and recommendations. (2010) (264)
Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. (2008) (251)
Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. (1995) (245)
Treatment-associated leukemia following testicular cancer. (2000) (243)
Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast (2018) (232)
ATM-heterozygous germline mutations contribute to breast cancer-susceptibility. (2000) (232)
Second cancer risk following testicular cancer: a follow-up study of 1,909 patients. (1993) (228)
Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). (2006) (224)
Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma (2015) (218)
Second cancers among long-term survivors of non-Hodgkin's lymphoma. (1993) (216)
Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK) (2012) (214)
Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. (2008) (214)
Physical activity and breast cancer risk in women aged 20-54 years. (2000) (210)
Lung Cancer after Treatment for Hodgkin's Disease: Focus on Radiation Effects (2003) (210)
Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group. (2006) (199)
A genome-wide association study of Hodgkin Lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21, and 10p14 (GATA3) (2010) (194)
Optimum number of oocytes for a successful first IVF treatment cycle. (2006) (193)
Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. (1994) (190)
Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study. (2006) (189)
Radiation Exposure From Pediatric CT Scans and Subsequent Cancer Risk in the Netherlands (2018) (181)
Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. (2008) (176)
Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic review. (2013) (176)
Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study. (2010) (172)
European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk. (2015) (169)
Body composition in children and adolescents born after in vitro fertilization or spontaneous conception. (2007) (169)
Risk of cancer in the offspring of women who underwent ovarian stimulation for IVF. (2001) (161)
Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. (2013) (160)
Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort (2011) (159)
Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines. (2017) (158)
The development of a prognostic score for patients with parotid carcinoma (1999) (157)
Growth during infancy and early childhood in relation to blood pressure and body fat measures at age 8-18 years of IVF children and spontaneously conceived controls born to subfertile parents. (2009) (153)
Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group. (2007) (151)
Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma. (2006) (145)
Reproductive and Hormonal Factors, and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Results from the International BRCA1/2 Carrier Cohort Study (2009) (143)
Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy. (2017) (143)
Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease. (1989) (143)
Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes. (2009) (142)
Growth and development of children born after in vitro fertilization. (2008) (138)
Cardiotoxic effects of tangential breast irradiation in early breast cancer patients: the role of irradiated heart volume. (2007) (136)
Physical Activity and Endometrial Cancer Risk, a Systematic Review of Current Evidence (2007) (130)
Treatment-related risk factors for premature menopause following Hodgkin lymphoma. (2008) (127)
A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. (2002) (125)
Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment. (2003) (119)
Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation. (2006) (119)
Maternal death related to IVF in the Netherlands 1984-2008. (2010) (114)
Cancer Risk Associated with Subfertility and Ovulation Induction: A Review (2000) (112)
Independent prognostic value of screen detection in invasive breast cancer. (2011) (112)
The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands (2007) (110)
The effect of age on treatment choice and survival in elderly breast cancer patients (1991) (107)
Risk of leukemia following treatment for non-Hodgkin's lymphoma. (1994) (104)
Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors. (2005) (103)
Early development of the metabolic syndrome after chemotherapy for testicular cancer. (2013) (103)
Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases. (2010) (99)
Risk of second malignancies in long-term survivors of childhood cancer. (2007) (98)
Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis (2015) (97)
Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. (2009) (97)
The role of genetic breast cancer susceptibility variants as prognostic factors. (2012) (95)
Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer. (2008) (95)
Stomach cancer risk after treatment for hodgkin lymphoma. (2013) (93)
Cancer risk in DES daughters (2010) (89)
Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment. (2016) (88)
Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study (2007) (88)
Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors. (2016) (83)
Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers. (2016) (82)
Prediction of Ischemic Heart Disease and Stroke in Survivors of Childhood Cancer. (2018) (81)
Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: Pooled results from three countries (2012) (81)
Excess Risk for Contralateral Breast Cancer in CHEK2*1100delC Germline Mutation Carriers (2004) (79)
Risk, Risk Factors, and Surveillance of Subsequent Malignant Neoplasms in Survivors of Childhood Cancer: A Review. (2018) (79)
Age at Menarche and Menopause and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study (2007) (79)
Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation. (2003) (78)
Birth weight and age at menarche in patients with polycystic ovary syndrome or diminished ovarian reserve, in a retrospective cohort. (2003) (78)
Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies. (2018) (78)
Does subfertility explain the risk of poor perinatal outcome after IVF and ovarian hyperstimulation? (2006) (76)
Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction. (2015) (76)
Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations (2013) (76)
Malignant mesothelioma after radiation treatment for Hodgkin lymphoma. (2009) (75)
Chemotherapy-related late adverse effects on ovarian function in female survivors of childhood and young adult cancer: A systematic review. (2017) (75)
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2019) (74)
Pubertal development in children and adolescents born after IVF and spontaneous conception. (2008) (73)
Employment and social benefits up to 10 years after breast cancer diagnosis: a population-based study (2016) (71)
Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study. (2006) (70)
Incidence of retinoblastoma in Dutch children conceived by IVF: an expanded study. (2009) (69)
Five Polymorphisms and Breast Cancer Risk: Results from the Breast Cancer Association Consortium (2009) (69)
Renal dysfunction and elevated blood pressure in long-term childhood cancer survivors. (2012) (66)
Cancer mortality in long-term survivors of retinoblastoma. (2009) (65)
Risk of diabetes mellitus in long-term survivors of Hodgkin lymphoma. (2014) (65)
Radiation Dose-Response for Risk of Myocardial Infarction in Breast Cancer Survivors (2019) (64)
Lycopene supplementation elevates circulating insulin-like growth factor binding protein-1 and -2 concentrations in persons at greater risk of colorectal cancer. (2007) (63)
Ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast Cancer. (2016) (63)
Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis. (2013) (62)
Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2012) (60)
Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands? (2007) (59)
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus (2016) (58)
Risk of multiple primary malignancies following treatment of Hodgkin lymphoma. (2014) (58)
Mammographic screening detects low-risk tumor biology breast cancers (2014) (57)
Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women (2017) (57)
Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups (2016) (57)
Current knowledge and future research directions in treatment-related second primary malignancies (2014) (57)
Risk of treatment-related esophageal cancer among breast cancer survivors. (2012) (56)
Radiation-associated breast tumors display a distinct gene expression profile. (2010) (55)
Risk and Temporal Changes of Heart Failure Among 5‐Year Childhood Cancer Survivors: a DCOG‐LATER Study (2018) (55)
Cancer risk in first generation migrants in North-Holland/Flevoland, The Netherlands, 1995-2004. (2007) (55)
Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: a systematic review. (2005) (54)
Adult height and age at menarche in childhood cancer survivors. (2001) (54)
Association of the Variants CASP8 D302H and CASP10 V410I with Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2010) (53)
RB1 mutations and second primary malignancies after hereditary retinoblastoma (2011) (53)
Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women (2016) (51)
Evaluation of late adverse events in long-term wilms' tumor survivors. (2010) (50)
Induced abortion and risk for breast cancer: reporting (recall) bias in a Dutch case-control study. (1996) (50)
Identification of Key Gaps in Cancer Survivorship Research: Findings From the American Society of Clinical Oncology Survey. (2016) (50)
Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era. (2018) (50)
Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study (2012) (49)
Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ (2017) (48)
Hodgkin lymphoma: Late effects of treatment and guidelines for surveillance. (2016) (48)
Using Web-Based and Paper-Based Questionnaires for Collecting Data on Fertility Issues Among Female Childhood Cancer Survivors: Differences in Response Characteristics (2011) (48)
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers (2012) (47)
Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer (2018) (47)
Increased stomach cancer risk following radiotherapy for testicular cancer (2013) (46)
Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients (2009) (45)
Factors impacting questionnaire response in a Dutch retrospective cohort study. (2004) (45)
Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations. (2000) (45)
Uterine function, pregnancy complications, and pregnancy outcomes among female childhood cancer survivors. (2019) (44)
Exceptions to the rule of informed consent for research with an intervention (2016) (44)
An assessment of the relative validity of retrospective interviewing for measuring dietary intake. (1983) (43)
Breast Implant-Associated Anaplastic Large-Cell Lymphoma in a Transgender Woman (2017) (43)
Residential Traffic Density and Cancer Incidence in Amsterdam, 1989–1997 (2004) (41)
Decreased risk of stroke among 10-year survivors of breast cancer. (2006) (41)
Do children make you happier? Sustained child-wish and mental health in women 11-17 years after fertility treatment. (2014) (41)
A trial of consent procedures for future research with clinically derived biological samples (2009) (41)
A reduced size of the ovarian follicle pool is associated with an increased risk of a trisomic pregnancy in IVF-treated women. (2010) (40)
Risk of acute myelogenous leukaemia and myelodysplasia following cancer treatment. (1996) (39)
Pancreatic cancer risk after treatment of Hodgkin lymphoma. (2014) (39)
Differences in breast cancer risk factors to neu (c-erbB-2) protein overexpression of the breast tumor. (1992) (39)
Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls (2010) (38)
The influence of adjuvant systemic regimens on contralateral breast cancer risk and receptor subtype. (2019) (38)
The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors. (2012) (37)
The role of exogenous hormones in the epidemiology of breast, ovarian and endometrial cancer. (1989) (37)
The spectrum of ATM missense variants and their contribution to contralateral breast cancer (2007) (37)
Validity of self-reported causes of subfertility. (2005) (37)
Predictors of an Invasive Breast Cancer Recurrence after DCIS: A Systematic Review and Meta-analyses (2019) (37)
Opt-out plus, the patients’ choice: preferences of cancer patients concerning information and consent regimen for future research with biological samples archived in the context of treatment (2008) (36)
Women's adjustment trajectories during IVF and impact on mental health 11-17 years later. (2016) (36)
p53 mutations in lung cancer following radiation therapy for Hodgkin's disease. (1996) (36)
Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma (2014) (35)
Dose-effect relationships for adverse events after cranial radiation therapy in long-term childhood cancer survivors. (2013) (35)
p53 mutations in cyclophosphamide-associated bladder cancer. (1998) (35)
Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers (2020) (35)
Self-reported behavioral and socioemotional functioning of 11- to 18-year-old adolescents conceived by in vitro fertilization. (2011) (35)
Obtaining 'fresh' consent for genetic research with biological samples archived 10 years ago. (2009) (34)
Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age (2018) (33)
PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents. (2018) (33)
Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients (2020) (32)
A nationwide study on reproductive function, ovarian reserve, and risk of premature menopause in female survivors of childhood cancer: design and methodological challenges (2012) (32)
Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients. (2018) (31)
Chemoreduction for retinoblastoma. (2003) (31)
Risk of benign gynaecological diseases and hormonal disorders according to responsiveness to ovarian stimulation in IVF: a follow-up study of 8714 women. (2003) (31)
Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma In Situ—A Nested Case–Control Study (2018) (30)
Risk of cancer in children and young adults conceived by assisted reproductive technology (2019) (30)
Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years. (2017) (29)
Toward the optimal strategy for sustained weight loss in overweight cancer survivors: a systematic review of the literature (2017) (29)
Effects of Lycopene on the Insulin-Like Growth Factor (IGF) System in Premenopausal Breast Cancer Survivors and Women at High Familial Breast Cancer Risk (2008) (29)
Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment (2016) (29)
Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer From the International Guideline Harmonization Group. (2020) (29)
The proportion of postmenopausal breast cancer cases in the Netherlands attributable to lifestyle-related risk factors (2015) (29)
Genetic variants in TGFβ-1 and PAI-1 as possible risk factors for cardiovascular disease after radiotherapy for breast cancer. (2012) (29)
Normal values for morphological abnormalities in school children (2006) (29)
Increased pancreatic cancer risk following radiotherapy for testicular cancer (2016) (28)
Incidence of cancer in the area around Amsterdam Airport Schiphol in 1988–2003: a population-based ecological study (2005) (28)
Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure. (2017) (28)
Cardiovascular Morbidity and Mortality After Treatment for Ductal Carcinoma In Situ of the Breast (2014) (28)
Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals (2017) (28)
p53 protein overexpression in relation to risk factors for breast cancer. (1996) (27)
Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study (2018) (26)
Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors (2017) (26)
Risk of third malignancies and death after a second malignancy in retinoblastoma survivors. (2010) (26)
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers (2015) (25)
Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers (2018) (25)
Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial Carcinomas. (2016) (25)
Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity (2019) (25)
Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study (2021) (25)
Risks for lymphoma and gastrointestinal carcinoma in patients with newly diagnosed adult-onset celiac disease: Consequences for follow-up (2018) (25)
High Hospitalization Rates in Survivors of Childhood Cancer: A Longitudinal Follow-Up Study Using Medical Record Linkage (2016) (25)
Hypertension in long-term survivors of childhood cancer: a nested case-control study. (2010) (24)
Risk of Symptomatic Stroke After Radiation Therapy for Childhood Cancer: A Long-Term Follow-Up Cohort Analysis. (2016) (24)
FGFR2 genotype and risk of radiation-associated breast cancer in Hodgkin lymphoma. (2012) (24)
Radiation-associated breast cancer and gonadal hormone exposure: a report from the Childhood Cancer Survivor Study (2017) (24)
Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma. (2019) (23)
The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations (2018) (23)
High‐throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium (2016) (23)
Risk and prognostic significance of metachronous contralateral testicular germ cell tumours (2012) (23)
High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors (2018) (23)
Heart failure after treatment for breast cancer (2019) (23)
Melanoma risk after ovarian stimulation for in vitro fertilization. (2015) (22)
Myocardial dysfunction in long‐term breast cancer survivors treated at ages 40–50 years (2019) (22)
Methods to Assess Adverse Health-Related Outcomes in Cancer Survivors (2011) (22)
Hormone replacement therapy in women treated for gynaecological malignancy. (1999) (22)
The Nightingale study: rationale, study design and baseline characteristics of a prospective cohort study on shift work and breast cancer risk among nurses (2014) (22)
Light therapy as a treatment of cancer-related fatigue in (non-)Hodgkin lymphoma survivors (SPARKLE trial): study protocol of a multicenter randomized controlled trial (2018) (22)
Prediction and clinical utility of a contralateral breast cancer risk model (2019) (22)
Genomic profile of endometrial tumors depends on morphological subtype, not on tamoxifen exposure (2010) (22)
Colorectal Adenomas and Cancers After Childhood Cancer Treatment: A DCOG-LATER Record Linkage Study (2018) (21)
Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group. (1994) (21)
Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000–2014 (2018) (21)
Isolated isoflavones do not affect the circulating insulin-like growth factor system in men at increased colorectal cancer risk. (2007) (21)
Are we improving the long-term burden of Hodgkin's lymphoma patients with modern treatment? (2007) (21)
Cancer incidence in Dutch Balkan veterans. (2013) (20)
Association of PAI‐1 gene polymorphism with survival and chemotherapy‐related vascular toxicity in testicular cancer (2010) (20)
Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid Carcinoma. (2020) (20)
Platinum exposure and cause‐specific mortality among patients with testicular cancer (2019) (20)
Cancer mortality after nasopharyngeal radium irradiation in the Netherlands: a cohort study. (2001) (20)
Increased prevalence of BRCA1/2 mutations in women with macro-textured breast implants and anaplastic large cell lymphoma of the breast. (2020) (19)
The Dutch Breast Implant Registry: Registration of Breast Implant–Associated Anaplastic Large Cell Lymphoma—A Proof of Concept (2019) (19)
Participation rates of childhood cancer survivors to self‐administered questionnaires: a systematic review (2017) (19)
Report on the International Colloquium on Cardio-Oncology (Rome, 12–14 March 2014) (2014) (19)
Recommendations for long-term follow-up of adults with heritable retinoblastoma. (2020) (18)
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study (2021) (18)
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study (2021) (18)
Estrogen receptor α wields treatment-specific enhancers between morphologically similar endometrial tumors (2017) (18)
Long-Term Risk of Skin Cancer Among Childhood Cancer Survivors: A DCOG-LATER Cohort Study. (2019) (17)
Risk of subsequent gastrointestinal cancer among childhood cancer survivors: A systematic review. (2016) (17)
Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium (2019) (17)
Long-term risk of secondary skin cancers after radiation therapy for Hodgkin's lymphoma. (2013) (16)
Reliability of preoperative breast biopsies showing ductal carcinoma in situ and implications for non-operative treatment: a cohort study (2019) (16)
[Consequences of diethylstilbestrol during pregnancy; 50 years later still a significant problem]. (2001) (15)
Risk of Colorectal Cancer After Ovarian Stimulation for In Vitro Fertilization. (2016) (15)
Discordant Marker Expression Between Invasive Breast Carcinoma and Corresponding Synchronous and Preceding DCIS (2019) (15)
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (15)
Evaluation of the Dutch BRCA1/2 clinical genetic center referral criteria in an unselected early breast cancer population (2014) (15)
Valvular abnormalities detected by echocardiography in 5-year survivors of childhood cancer: a long-term follow-up study. (2015) (14)
Re: More about second cancers after retinoblastoma. (2008) (14)
Regulatory aspects of genetic research with residual human tissue: effective and efficient data coding. (2009) (14)
Chromosome 20 loss is characteristic for Breast implant-Associated Anaplastic Large Cell Lymphoma. (2020) (14)
Cardiovascular morbidity after radiotherapy or chemoradiation in patients with cervical cancer. (2010) (14)
Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects (2017) (14)
Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies (PanCareLIFE) (2018) (13)
Risk of treatment-related esophageal cancer among breast cancer survivors. (2012) (13)
Agreement between oral contraceptive users and prescribers: implications for case-control studies. (1992) (13)
Breast Implant Prevalence in the Dutch Female Population Assessed by Chest Radiographs (2019) (13)
Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study (2020) (13)
Incidence of and Risk Factors for Histologically Confirmed Solid Benign Tumors Among Long-term Survivors of Childhood Cancer (2019) (12)
The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer (2003) (12)
Variation in Mutation Spectrum Partly Explains Regional Differences in the Breast Cancer Risk of Female BRCA Mutation Carriers in the Netherlands (2014) (12)
Anthracyclines and Alkylating Agents: New Risk Factors for Breast Cancer in Childhood Cancer Survivors? (2016) (12)
[Incidence of cervical cancer in women in North-Holland by country of birth from 1988-1998]. (2003) (12)
The number of retrieved oocytes does not decrease during consecutive gonadotrophin-stimulated IVF cycles. (2004) (12)
High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial. (2020) (12)
Risk of diabetes after para-aortic radiation for testicular cancer (2018) (12)
Cancer Incidence After Nasopharyngeal Radium Irradiation (2002) (12)
Prevalence of gynecologic cancer in women exposed to diethylstilbestrol in utero. (2000) (12)
Factors associated with an adverse work outcome in breast cancer survivors 5–10 years after diagnosis: a cross-sectional study (2019) (12)
Simple method to estimate mean heart dose from Hodgkin lymphoma radiation therapy according to simulation X-rays. (2015) (12)
The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors. (2012) (11)
The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study (2017) (11)
High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors (2018) (11)
Clinical heterogeneity of hereditary breast cancer and its impact on screening protocols: the Dutch experience on 24 families under surveillance. (1993) (11)
Diagnostic tools for early detection of cardiac dysfunction in childhood cancer survivors: Methodological aspects of the Dutch late effects after childhood cancer (LATER) cardiology study. (2019) (11)
Risk and associated risk factors of hospitalization for specific health problems over time in childhood cancer survivors: a medical record linkage study (2017) (11)
Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors: investigating dose-effect relationships in a European case-control study (PanCareLIFE). (2021) (10)
[Insufficient basis for the inclusion of Human papillomavirus vaccination in the National Immunisation Programme in The Netherlands]. (2008) (10)
Connective tissue: Cancer patients’ attitudes towards medical research using excised (tumour) tissue (2011) (10)
A detailed insight in the high risks of hospitalizations in long-term childhood cancer survivors—A Dutch LATER linkage study (2020) (10)
The involvement of primary care physicians in care for childhood cancer survivors (2019) (10)
Prevalence and risk factors of cancer‐related fatigue in childhood cancer survivors: A DCCSS LATER study (2021) (10)
A cohort study of cancer mortality among Biology Research Laboratory workers in The Netherlands (2004) (9)
[Secondary use of human tissue: consent and better information required]. (2009) (9)
Validation study suggested no differential misclassification of self-reported mammography history in BRCA1/2 mutation carriers. (2011) (9)
No Effect of Red Clover–Derived Isoflavone Intervention on the Insulin-Like Growth Factor System in Women at Increased Risk of Colorectal Cancer (2008) (8)
Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma. (2020) (8)
Low prevalence of male microchimerism in women with Mayer–Rokitansky–Küster–Hauser syndrome (2019) (8)
Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design (2017) (8)
Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer. (1991) (8)
[The BETER survivorship care initiative for Hodgkin lymphoma; tailored survivorship care for late effects of treatment]. (2015) (8)
Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology. (2020) (8)
Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study) (2020) (8)
[Contribution of lifestyle factors to cancer: secondary analysis of Dutch data over 2010 and a projection for 2020]. (2014) (8)
Detection of Subclinical Cardiovascular Disease by Cardiovascular Magnetic Resonance in Lymphoma Survivors (2021) (7)
A Randomised Controlled Trial of Consent Procedures for the Use of Residual Tissues for Medical Research: Preferences of and Implications for Patients, Research and Clinical Practice (2016) (7)
Subsequent Malignant Neoplasms in Retinoblastoma Survivors (2021) (7)
Cardiovascular morbidity and mortality in patients treated for ductal carcinoma in situ of the breast. (2013) (7)
Risk of digestive cancers in a cohort of 69 460 five-year survivors of childhood cancer in Europe: the PanCareSurFup study (2020) (7)
Risk factors for the incidence of second cancers in survivors of retinoblastoma with a family history. (2012) (7)
Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function (2021) (6)
Increased breast cancer risk in in vitro fertilisation treated women with a multiple pregnancy: a new hypothesis based on historical in vitro fertilisation treatment data. (2015) (6)
Benign Tumors in Long-Term Survivors of Retinoblastoma (2021) (6)
Breast Cancer After Childhood, Adolescent, and Young Adult Cancer: It's Not Just About Chest Radiation. (2017) (6)
Effect of Web-Based Versus Paper-Based Questionnaires and Follow-Up Strategies on Participation Rates of Dutch Childhood Cancer Survivors: A Randomized Controlled Trial (2015) (6)
Diagnostic Accuracy of Stool Tests for Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors (2020) (6)
[Trends in cancer incidence and cancer mortality in Netherlands: good and bad news]. (1999) (6)
Development and Validation of a Breast Cancer Risk Prediction Model for Childhood Cancer Survivors Treated With Chest Radiation: A Report From the Childhood Cancer Survivor Study and the Dutch Hodgkin Late Effects and LATER Cohorts (2021) (5)
Factors associated with dizygotic twinning after IVF treatment with double embryo transfer. (2012) (5)
Light Therapy for Cancer-Related Fatigue in (Non-)Hodgkin Lymphoma Survivors: Results of a Randomized Controlled Trial (2021) (5)
Dose-volume effects of breast cancer radiation therapy on the risk of second oesophageal cancer. (2020) (5)
Setting up a national infrastructure for survivorship care after treatment for Hodgkin lymphoma (2019) (5)
Risk of cervical intra-epithelial neoplasia and invasive cancer of the cervix in DES daughters. (2017) (5)
Re: Late effects from radiation therapy: the hits just keep on coming. (2010) (5)
Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort (2019) (5)
Comparing causes of death of Hodgkin lymphoma and breast cancer patients between medical records and cause-of-death statistics (2018) (5)
Overall and disease‐specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer (2018) (5)
Cohort profile: LIFEWORK, a prospective cohort study on occupational and environmental risk factors and health in the Netherlands (2018) (5)
Retrospective methods to estimate radiation dose at the site of breast cancer development after Hodgkin lymphoma radiotherapy (2017) (5)
[Postmenopausal hormone replacement therapy and cancer of the female genitalia and breast]. (1997) (5)
Prognosis of acute coronary syndromes after radiotherapy for breast cancer. (2020) (4)
Long-term effects of adjuvant treatment for breast cancer on carotid plaques and brain perfusion (2020) (4)
Re: Smoking, treatment for Hodgkin's disease, and subsequent lung cancer risk. (1996) (4)
Questionnaire‐ and linkage‐based outcomes in Dutch childhood cancer survivors: Methodology of the DCCSS LATER study part 1 (2022) (4)
Cancer-related Fatigue in Relation to Chronotype and Sleep Quality in (Non-)Hodgkin Lymphoma Survivors (2021) (4)
Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups (2016) (4)
Studying Hospitalizations and Mortality in the Netherlands: Feasible and Valid Using Two-Step Medical Record Linkage with Nationwide Registers (2015) (4)
Development and Validation of Risk Prediction Models for Coronary Heart Disease and Heart Failure After Treatment for Hodgkin Lymphoma (2022) (3)
Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study (2021) (3)
Tamoxifen, balancing risks and benefits. (1996) (3)
[Cancer incidence in the Schiphol area in 1988-1993]. (1997) (3)
Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma (2022) (3)
[The Dutch Cancer Society Cancer Risk Test]. (2012) (3)
Cardiovascular Disease Risk After Treatment-Induced Premature Ovarian Insufficiency in Female Survivors of Hodgkin Lymphoma. (2018) (3)
Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies. (2022) (3)
Physical Activity and Cardiac Function in Long-Term Breast Cancer Survivors (2022) (3)
Clinical characteristics of subsequent histologically confirmed meningiomas in long-term childhood cancer survivors: A Dutch LATER study. (2021) (3)
Clinical evaluation of late outcomes in Dutch childhood cancer survivors: Methodology of the DCCSS LATER 2 study (2023) (3)
Female reproductive function after treatment of childhood acute lymphoblastic leukemia (2021) (3)
Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin’s lymphoma: influence on long-term adverse effects (SOPHIA) (2018) (3)
Re: Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. (2003) (2)
Male breast cancer after childhood cancer: Systematic review and analyses in the PanCareSurFup cohort. (2022) (2)
Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits (2022) (2)
Cohort profile: Risk and risk factors for female breast cancer after treatment for childhood and adolescent cancer: an internationally pooled cohort (2022) (2)
Psychosocial factors and cancer incidence (PSY‐CA): Protocol for individual participant data meta‐analyses (2021) (2)
Response to Wollschläger, Blettner, and Pokora. (2019) (2)
Re: Radiation therapy in the treatment of Hodgkin's disease--do you see what I see? (2004) (2)
[Grounds for the inclusion of vaccination against cervical cancer within the National Immunisation Programme]. (2008) (2)
Breast Cancer After Childhood, Adolescent, and Young Adult Cancer: It's Not Just About Chest Radiation. (2017) (2)
Macrotextured Breast Implants with Defined Steps to Minimize Bacterial Contamination around the Device: Experience in 42,000 Implants. (2018) (2)
Are cause of subfertility and in vitro fertilization treatment risk factors for an earlier start of menopause? (2005) (2)
RISK OF HORMONE-RELATED CANCERS AFTER OVARIAN STIMULATION FOR IVF IN A COHORT OF 25,152 WOMEN (2004) (2)
Breast Cancer Risk After Ovarian Stimulation for In Vitro Fertilization-Reply. (2016) (2)
Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers (2018) (1)
Diagnostic yield of colonoscopy surveillance in testicular cancer survivors treated with platinum-based chemotherapy: study protocol of a prospective cross-sectional cohort study (2021) (1)
Bias correction for estimates from linear excess relative risk models in small case‐control studies (2021) (1)
Prediction and clinical utility of a contralateral breast cancer risk model (2019) (1)
Single‐item chronotype is associated with dim light melatonin onset in lymphoma survivors with fatigue (2022) (1)
[Silicone breast implants: the importance of nuanced reporting]. (2022) (1)
On the reliability of historical dietary information. (1986) (1)
Exposure of the heart and cardiac valves in women irradiated for breast cancer 1970–2009 (2022) (1)
Association of plasminogen-activator inhibitor 1 (PAI-1) 4G/5G gene polymorphism with survival and chemotherapy-related vascular toxicity in non-seminomatous testicular cancer (TC). (2009) (1)
Dietary guidelines for cancer prevention: the etiology of a confused debate. (1986) (1)
Radiotherapy-Related Dose and Irradiated Volume Effects on Breast Cancer Risk Among Hodgkin Lymphoma Survivors (2022) (1)
Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma (2023) (1)
A systematic review: Childhood cancer survivors and gastrointestinal cancer. (2017) (1)
Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: Pooled results from three countries (2012) (1)
[No convincing evidence for a causal relationship between childhood nasopharyngeal radium irradiation and head-neck tumors or hormone-related disorders later in life; a retrospective cohort study]. (2004) (1)
Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma-Reply. (2018) (1)
Reply to D. Vordermark and T. Pelz and R. Mazzola et al. (2016) (1)
[Does breast feeding protect against breast cancer? An epidemiological study]. (1992) (1)
Silicone Particle Migration: A Misleading Report (2021) (1)
Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy (2022) (1)
Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases (2020) (1)
Pathology review identifies frequent misdiagnoses in recurrent classic Hodgkin lymphoma in a nationwide cohort: implications for clinical and epidemiological studies (2022) (1)
Late Mortality in Childhood Cancer Survivors according to Pediatric Cancer Diagnosis and Treatment Era in the Dutch LATER Cohort (2022) (1)
Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of Life. (2023) (1)
Patients' Attitudes Towards the Return of Incidental Findings After Research with Residual Tissue: A Mixed Methods Study. (2018) (1)
[Settlement effected for damages for victims of diethylstilbestrol (DES)]. (2007) (0)
RB1 mutations and second primary malignancies after hereditary retinoblastoma (2011) (0)
Dissent: The risk of lung cancer in nonsmokers in the United States: a causal association with environmental tobacco smoke. (1995) (0)
Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on cognition in women with high familial risk of ovarian cancer: A cross-sectional study. (2023) (0)
P1-46 Diagnostic radiation exposure and breast cancer risk in BRCA1/2 mutation carriers in the gene-rad-risk study (2011) (0)
2022-RA-1488-ESGO Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on cognition in women with high familial risk of ovarian cancer (2022) (0)
Abstract GS2-09: Tamoxifen instigates uterine cancer development by activating PI3K signaling and supersedes PIK3CA driver mutations (2022) (0)
Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design (2017) (0)
Fatigue, Neuropathy, Psychological Distress and Their Association with Health-Related Quality of Life in Survivors of Diffuse Large B-Cell Lymphoma: A Prospective Cohort Study and Comparison with a Normative Population (2022) (0)
A nationwide study on reproductive function, ovarian reserve, and risk of premature menopause in female survivors of childhood cancer: design and methodological challenges (2012) (0)
Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy. (2022) (0)
P080: The BETER-REFLECT Biobank: a REsource For studies on Late Effects of Cancer Treatment (2022) (0)
Risk of diabetes after para-aortic radiation for testicular cancer (2018) (0)
Chemotherapy-related late adverse effects on ovarian function in female survivors of childhood cancer and cancer in the reproductive age (2019) (0)
Surgical outcomes following breast reconstruction in patients with and without a history of chest radiotherapy for hodgkin lymphoma: a multicenter, matched cohort study. (2023) (0)
Exceptions to the rule of informed consent for research with an intervention (2016) (0)
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers (2015) (0)
Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer (2022) (0)
Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers (2020) (0)
P073: Increased risk of colorectal cancer following treatment for Hodgkin lymphoma (2022) (0)
Hemochromatosis gene (HFE) mutations and chemotherapy-related cardiovascular risk profile in testicular cancer survivors (TCS). (2016) (0)
P2-246 The Nightingale Study: a prospective cohort study on shift work and breast cancer among nurses in the Netherlands (2011) (0)
Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers (2020) (0)
2022-RA-1498-ESGO Urinary incontinence in women with premenopausal risk-reducing salpingo-oophorectomy compared with women with postmenopausal risk-reducing salpingo-oophorectomy (2022) (0)
Risk of ovarian cancer in women who give birth after assisted reproductive technology (ART)—a registry-based Nordic cohort study with follow-up from first pregnancy (2022) (0)
OVERALL AND DISEASE‐SPECIFIC SURVIVAL OF PATIENTS WHO SURVIVED HODGKIN LYMPHOMA AND DEVELOPED GASTROINTESTINAL CANCER (2017) (0)
Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin’s lymphoma survivors (2021) (0)
Cardiovascular risk factors and arterial wall properties in childhood cancer survivors; a long-term follow-up. (2004) (0)
Somatic hits in mismatch repair genes in colorectal cancer among non-seminoma testicular cancer survivors (2022) (0)
Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials: A study based on the EORTC‐Dutch late effects cohort‐linked data (2022) (0)
Bradford Hill and breast implant illness: no evidence for causal association with breast implants (2022) (0)
Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer (2018) (0)
Special Departments (1867) (0)
0032: Risk of Hormone-Related Cancers After Ovarian Stimulation for in Vitro Fertilization in a Cohort of 26,428 Women (2006) (0)
Light therapy as a treatment of cancer-related fatigue in (non-)Hodgkin lymphoma survivors (SPARKLE trial): study protocol of a multicenter randomized controlled trial (2018) (0)
T064: Doxorubicin exposure and breast cancer risk in adolescent and adult Hodgkin lymphoma survivors (2022) (0)
Reply to “Can we avoid thoracic radiotherapy in young females with Hodgkin lymphoma?” (2023) (0)
The Areola study: design and rationale of a cohort study on long-term health outcomes in women with implant-based breast reconstructions. (2023) (0)
P071: First results of cardiovascular screening in a survivorship care program for Hodgkin lymphoma survivors in the Netherlands (2022) (0)
The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study (2017) (0)
Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors (2022) (0)
RISK OF CANCER IN OFFSPRING OF WOMEN WHO UNDERWENT IN VITRO FERTILIZATION (2001) (0)
The Nightingale study: rationale, study design and baseline characteristics of a prospective cohort study on shift work and breast cancer risk among nurses (2014) (0)
Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study) (Preprint) (2020) (0)
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2020) (0)
Effects of estrogen-only treatment in postmenopausal women. (2004) (0)
P070: Design of the INSIGHT study, evaluation of long-term follow-up care for lymphoma survivors in the Netherlands: does survivorship care at the BETER clinics reduce morbidity and mortality from late effects of lymphoma treatment and associated costs? (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Flora E. Van Leeuwen?

Flora E. Van Leeuwen is affiliated with the following schools:

Ohio State University
University of Cambridge